Related Experiment Video
Updated: Apr 18, 2026

08:51
The Use of Thermal Infra-Red Imaging to Detect Delayed Onset Muscle Soreness
Published on: January 22, 2012
19.9K
Delayed-onset muscle soreness: a pilot study to assess analgesic study design features
Neil Singla1, Paul J Desjardins, Evelyn B Cosca
1Department of Anesthesia, Lotus Clinical Research, Huntington Hospital, Pasadena, CA, USA, Department of Diagnostic Sciences, Rutgers School of Dental Medicine, Newark, NJ, USA.
Pain
|January 31, 2015
Summary
Topical diclofenac sodium gel 1% effectively reduced pain from delayed-onset muscle soreness (DOMS) compared to placebo. This study followed best practices for analgesic research in the DOMS model.
Area of Science:
- Exercise Physiology
- Pain Research
- Pharmacology
Background:
- Delayed-onset muscle soreness (DOMS) research often lacks adherence to acute pain study design standards.
- Established analgesic study designs can improve assay sensitivity in DOMS models.
Purpose of the Study:
- To assess the efficacy of topical diclofenac sodium 1% versus placebo for DOMS pain.
- To implement rigorous study design standards in a DOMS analgesic investigation.
Main Methods:
- Randomized, double-blind, placebo-controlled, within-subject design.
- Topical diclofenac sodium gel 1% applied every 6 hours for 48 hours to one leg, placebo to the other.
- Pain intensity assessed at rest, standing, and walking.
Main Results:
- Diclofenac sodium gel 1% significantly reduced walking pain intensity at 24 hours (SPID 24 = 34.9) compared to placebo (SPID 24 = 23.6; P = 0.032).
- The study design demonstrated reasonable assay sensitivity.
Conclusions:
- Topical diclofenac sodium gel 1% is effective for managing DOMS pain.
- Adherence to analgesic research best practices enhances DOMS study validity and assay sensitivity.
Related Concept Videos
Analgesia and Pain Management
3.2K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.2K
Skeletal Muscle Relaxants: Adverse Effects
1.1K
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
1.1K

